Mineralys achieved positive Phase 2 results in CKD patients with hypertension. Click here to find out why MLYS stock is a Strong Buy.

Honolulu police are investigating a gunpoint robbery and ATM theft at a gas station in Waipio early this morning. Honolulu Police Department District 3 Patrol officers responded to the robbery at a ...

PARIS — An investigational oral interleukin-23 (IL-23) inhibitor performed better and with fewer side effects than an established targeted oral agent for moderate-to-severe plaque psoriasis in two ...

WAS STILL ABLE TO GET IN. SHAWNA JOHNSON HAS WATCHED LOTS OF PEOPLE COME THROUGH SALEM OVER THE YEARS. DESPITE THE CROWDS, ONE THING HAS STAYED THE SAME. IT’S STILL A REALLY SAFE PLACE TO BE, AND ...

Clinicians in Europe may soon gain access to a first-in-class neonatal Fc receptor (FcRn) inhibitor for generalized myasthenia gravis (gMG). Imaavy (nipocalimab; Janssen-Cilag International) received ...

What began with a Plano resident reporting a strange incident at his drive-up ATM led to the capture of an international fugitive and a warning about a little-known scheme called ‘cash trapping.’ A ...

Schrödinger is abandoning its CDC7 inhibitor after the therapy was linked to the deaths of two patients in a phase 1 leukemia trial. The biotech had been evaluating the asset, dubbed SGR-2921, in an ...

Seven months after pressing pause on its plans for its PKMYT1 inhibitor, Repare Therapeutics has found a partner to take the cancer drug forward. Back in January, Repare abandoned phase 3 plans to ...

Brain penetrant histone deacetylase inhibitors (HDACi) are promising radiosensitizing agents for glioblastoma (GBM). In addition to suppression of HDAC activity, the antiproliferative effect of HDACi ...

Use of SGLT2 inhibitors before emergency surgery was not associated with an increased risk for postoperative diabetic ketoacidosis. The FDA previously issued guidance on withholding SGLT2 inhibitors ...

Genomic alterations in circulating tumor DNA (ctDNA) and response to telisotuzumab adizutecan (ABBV-400) treatment in patients (pts) with colorectal cancer (CRC). A comparison of real-world outcomes ...